National Stock Number
6505-00-926-9083
National Stock Number (NSN) 6505-00-926-9083, or NIIN 009269083, (atropine injection) was assigned November 25, 1966 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Nov 28, 2012. There have been 2 contracts issued for this part number, with 5 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPM2DP11D0002, SPM2DP11D0002, SPM2DP11D0002, SPM20005D0010, SPM20005D0010. The total value of the awarded contracts has been US$ 9,202,795.00.
This NSN is very common among different weapons systems, belonging to 32 different platforms.
There has been very little demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) The Government has unlimited rights to the technical data, and the data package is complete. Valid AMCs: 1 and 2.
This NSN is assigned to Item Name Code (INC) 09296. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Information is in the Hazardous Materials Information Resource System (HMIRS). NSN 6505009269083 does not contain precious metals.
This NSN is associated to Schedule B 2933997000: drugs primarily affecting the central nervous system, not elsewhere specified or included. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325411: medicinal and botanical manufacturing.
This information was last updated on Jul 01, 2025.